GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.

The US Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

At 12 months, risk factors for persistence of long COVID symptoms included male sex, fever, and taste disorder.

Gout was associated with increased risks for CV events and all-cause mortality, even after adjusting for long-term CV risk profiles and their changes.

The American Heart Association’s (AHA) Scientific Sessions 2025 begin today in New Orleans, Louisiana, and the Cardiology Advisor team is excited to bring to our readers the latest research and ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

At 12 weeks, a combination pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP in patients with hypertension.

Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.